The evolving landscape of Plasmodium falciparum necessitates a dynamic approach to management protocols. Current recommendations, often guided by the World Health Organization WHO, prioritize the use of artemisinin-based combination treatments (ACTs) as first-line management in most endemic regions. However, the rise of artemisinin tolerance demand

A revolutionary drug is generating optimism in the medical community, as it shows encouraging results for both weight loss and diabetes management. In ongoing clinical trials, individuals taking the medication experienced substantial reductions in BMI. Moreover, the drug also demonstrated positive effects in blood sugar control for patients with ty